| A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules A Aspelund, S Antila, ST Proulx, TV Karlsen, S Karaman, M Detmar, ... Journal of Experimental Medicine 212 (7), 991-999, 2015 | 2163 | 2015 |
| Development and plasticity of meningeal lymphatic vessels S Antila, S Karaman, H Nurmi, M Airavaara, MH Voutilainen, T Mathivet, ... Journal of Experimental Medicine 214 (12), 3645-3667, 2017 | 410 | 2017 |
| Lymphatic system in cardiovascular medicine A Aspelund, MR Robciuc, S Karaman, T Makinen, K Alitalo Circulation research 118 (3), 515-530, 2016 | 382 | 2016 |
| Lymphangiogenic factors, mechanisms, and applications W Zheng, A Aspelund, K Alitalo The Journal of clinical investigation 124 (3), 878-887, 2014 | 334 | 2014 |
| The Schlemm’s canal is a VEGF-C/VEGFR-3–responsive lymphatic-like vessel A Aspelund, T Tammela, S Antila, H Nurmi, VM Leppänen, G Zarkada, ... The Journal of clinical investigation 124 (9), 3975-3986, 2014 | 240 | 2014 |
| The lymphatic system S Karaman, A Aspelund, M Detmar, K Alitalo ESC Textbook in Vascular Biology, 123-137, 2017 | 14 | 2017 |
| Yoda1 opens the lymphatic path for craniosynostosis therapy A Aspelund, K Alitalo The Journal of Clinical Investigation 134 (4), 2024 | 5 | 2024 |
| Discovery of dural lymphatic vessels and the lymphatic-like phenotype of Schlemm’s canal A Aspelund University of Helsinki, 2024 | | 2024 |
| Näköharhat riesana: vinkistä vihiä+ ratkaisu K Hirvonen, A Aspelund, E Pekkonen Duodecim 140 (13-14), 1155-1157, 2024 | | 2024 |
| Therapeutic use of vegfr-3 ligands K Alitalo, A Aspelund, T Tammela, I Immonen US Patent App. 15/112,858, 2016 | | 2016 |
| Therapeutic Insights to Lymphangiogenic Growth Factors A Aspelund, T Tammela, S Antila, H Nurmi, VM Leppanen, G Zarkada, ... Journal of Vascular Research 52 (Suppl. 1), 19-19, 2015 | | 2015 |
